1-9 of 9
Stefan Suciu, PHD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Age and Treatment Group in Childhood High Hyperdiploid Low Risk B-Cell Acute Lymphoblastic Leukemia (ALL): Results of the CLG-EORTC 58951 Study

Laura Clement, Stefan Suciu, PhD, Isabelle Luquet, MD, Alina Ferster, MD PhD, Karima Yakouben, MD, Anne Uytterbroeck, Catherine Paillard, MD PhD, Nicolas Sirvent, Vitor Costa, Barbara De Moerloose, MD, Francoise Mazingue, Emmanuel Plouvier, MD, Martine Munzer, Maryline Poirée, Odile Minckes, MD, Frédéric Millot, MD, Dominique Plantaz, Caroline Piette, Frank Speleman, Prof, Hélène Cavé, Jutte VanderWerff-tenBossch, Pierre Simon Rohrlich, MDPhD, Yves Bertrand, Yves Benoit, Geneviève Plat
Journal: Blood
Blood (2016) 128 (22): 1743.
https://doi.org/10.1182/blood.V128.22.1743.1743
Published: 2016
Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD
Journal: Blood
Blood (2016) 128 (22): 2847.
https://doi.org/10.1182/blood.V128.22.2847.2847
Published: 2016
Journal Articles

Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups

Sergio Amadori, MD, Stefan Suciu, PhD, Dominik Selleslag, MD, Elena Rossetti, MD, Gianluca Gaidano, MD PhD, Maurizio Musso, MD, Luciana Annino, MD, Adriano Venditti, Domenico Magro, MD, Paolo de Fabritiis, MD, Petra Muus, MD, Giuliana Alimena, MD, Marco Mancini, Anne Hagemeijer, MD, Francesca Cotugno, Marco Vignetti, MD, Paola Fazi, MD, Liv Meert, MSc, Safaa M Ramadan, MD PhD, Roelof Willemze, MD PhD, Theo de Witte, MD, Frederic Baron
Journal: Blood
Blood (2014) 124 (21): 619.
https://doi.org/10.1182/blood.V124.21.619.619
Published: 2014
Journal Articles

Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group

Heiko Becker, MD, Stefan Suciu, PhD, Björn Rüter, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, Dominik Selleslag, MD, Boris Labar, MD, PhD, Ulrich Germing, MD, Helmut R. Salih, MD, Petra Muus, MD, PhD, Karl-Heinz Pflüger, MD, Anne Hagemeijer, MD, PhD, Hans-Eckart Schaefer, MD, Frédéric Baron, MD, PhD, Arnold Ganser, MD, Carlo Aul, MD, Theo de Witte, MD, Pierre W. Wijermans, MD, Michael Lübbert, MD
Journal: Blood
Blood (2013) 122 (21): 1452.
https://doi.org/10.1182/blood.V122.21.1452.1452
Published: 2013
Journal Articles

Aberrant 5-Hydroxymethylcytosine Levels Correlate With Poor Overall Survival In Acute Myeloid Leukemia

Leonie I Kroeze, Mariam G Aslanyan, Arno van Rooij, Theresia N Koorenhof-Scheele, Marion Massop, Thomas Carell, Jan B Boezeman, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD, PhD, Theo M. de Witte, MD, Gerwin Huls, Stefan Suciu, PhD, Ron Wevers, Bert A. van der Reijden, Joop H. Jansen, PhD
Journal: Blood
Blood (2013) 122 (21): 1261.
https://doi.org/10.1182/blood.V122.21.1261.1261
Published: 2013
Journal Articles

Survival Improvement Of Secondary Acute Myeloid Leukemia Over Time: Experience From 962 Patients Included In 13 EORTC-Gimema-HOVON Leukemia Group Trials

Safaa M. Ramadan, MD, PhD, Stefan Suciu, PhD, Marian J.P.L. Stevens-Kroef, PhD, Roelof Willemze, MD, PhD, Sergio Amadori, Theo de Witte, MD, Bob Lowenberg, MD, PhD, Petra Muus, MD, PhD, Boris Labar, MD, PhD, Liv Meert, Gaetan de Schaetzen, Giovanna Meloni, MD, Giuseppe Leone, MD, Marco Vignetti, Franco Mandelli, MD, Frederic Baron, MD, PhD, Jean-Pierre Marie, MD
Journal: Blood
Blood (2013) 122 (21): 829.
https://doi.org/10.1182/blood.V122.21.829.829
Published: 2013
Journal Articles

The EORTC Cutaneous T-Cell Lymphoma (CTCL) Platform

Sean Whittaker, Robert Knobler, Pablo Luis Ortiz-Romero, Maarten Vermeer, Matthias Karrasch, Baktiar Hasan, Stefan Suciu, PhD, Denis Lacombe, Martine Bagot
Journal: Blood
Blood (2010) 116 (21): 4896.
https://doi.org/10.1182/blood.V116.21.4896.4896
Published: 2010
Journal Articles

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Boris Labar, MD, PhD, Stefan Suciu, PhD, Petra Muus, MD, Roelof Willemze, MD, PhD, Jean-Pierre Marie, MD, Georges Fillet, MD, Zwi Berneman, MD, Branimir Jaksic, MDPhD, Walter Feremans, MD, Dominique Bron, MD, Henry Sinnige, MD, Martin Mistrik, MD, G. Vreugdenhil, MD, Robrecht De Bock, MD, Damir Nemet, MD, Caroline Gilotay, Theo de Witte, MDPhD, Sergio Amadori, MD
Journal: Blood
Blood (2005) 106 (11): 1834.
https://doi.org/10.1182/blood.V106.11.1834.1834
Published: 2005
Journal Articles

Is CDKN2A +/− CDKN2B and MTAP Inactivation of Prognostic Significance in B-Precursor Childhood Acute Lymphoblastic Leukemia? Results of EORTC Studies 58881 and 58951.

Delphine Mirebeau, MD, Cécile Acquaviva, PharmD, Stefan Suciu, PHD, Raphaëlle Bertin, PharmD, Alain Robert, MD, Patrick Boutard, MD, Françoise Méchinaud, MD, Emmanuel Plouvier, MD, Jacques Otten, MD, Etienne Vilmer, MD, Hélène Cavé, PharmD, PHD
Journal: Blood
Blood (2004) 104 (11): 1076.
https://doi.org/10.1182/blood.V104.11.1076.1076
Published: 2004